Dr. Landis is a multiple time recipient of the Seattle Top Doctor Award and most recently received the 2024 Seattle Magazine Top Doc Award. He truly enjoys the challenge of caring for cancer patients. A diagnosis of cancer can be overwhelming for a patient and their family. From the beginning he will review the diagnosis in detail, the treatment options, and the potential results of each option, including possible side effects. Dr. Landis enjoys seeing his patients over time, during the course of treatment, and in follow-up. Often it takes some time to understand the patients priorities and wishes. As a physician, he believes in prioritizing the patients quality of life and listening to understand their desires and incorporate this into an individualized treatment plan. He strives to provide the best possible care to all of his patients. Dr. Landis is rated as a Distinguished provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Nasopharyngeal Carcinoma, Prostate Cancer, Familial Prostate Cancer, and Posterior Fossa Tumor.

Physicians have the great privilege of being entrusted to guide patients on a path to better health. Oncologists have the difficult task of rendering therapies which can add years of life but may take from the quality of those years. My desire to add quality and years to my patients lives is what drives me to do cancer research. Dr. Meier is a multiple time recipient of the Seattle Top Doctor Award and most recently received the 2024 Seattle Magazine Top Doc Award. Dr. Meier is rated as an Advanced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, and Muscle Invasive Bladder Cancer.

Dr. Patel is a neurosurgeon at the Swedish Neuroscience Institute. His philosophy of care is to provide comprehensive care and superior service in order to help and change the lives of his patients for the better. Dr. Patel is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Brain Aneurysm, Stroke, Subdural Hematoma, Cerebral Artery Bypass Surgery, and Extracranial-Intracranial Bypass Surgery.

Dr. Monteith's philosophy of care is to approach the care of each of his patients as if they were a member of his own family. He strives to give his patients the best possible outcome by combining the latest technological advances with personalized clinical care. When possible, he uses endovascular or minimally invasive surgical approaches, so that his patients can recover from their procedure and get back to their normal lives as soon as possible. Dr. Monteith is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Brain Aneurysm, Congenital Cardiovascular Shunt, Normal Pressure Hydrocephalus, Extracranial-Intracranial Bypass Surgery, and Cerebral Artery Bypass Surgery.

Dr. Litvack values a collaborative multi-disciplinary approach to caring for patients suffering from benign or malignant brain tumors, head and neck cancers involving the brain and spine, chronic pain and degenerative spinal disorders. Dr. Litvack applies his unique expertise in skull base surgery, neuroendoscopy, minimally invasive cranial, and minimally invasive spinal surgery to restore patients to health while minimizing the physical and emotional impact of surgery. His patients benefit from being fully informed of their disease and their treatment options. Dr. Litvack and his patients also benefit from 24/7 access to a team of fellowship-trained physicians and surgeons with extensive experience in Neurosurgery, Otolaryngology, Neuroanesthesia, Neuro-endocrinology, Neuro-ophthalmology, Neuro-Oncology and Radiation Oncology. Dr. Litvack has also been selected by Seattle Magazine and Seattle Metropolitan Magazine as a Top Doctor in the field of Neurosurgery. Dr. Litvack is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Pituitary Tumor, Prolactinoma, Hypothalamic Tumor, Balloon Sinuplasty, and Awake Craniotomy.

Dr. Sui earned a medical degree from Qingdao University, China, and a Ph.D. from the University of Tokyo, Japan. He conducted postdoctoral research in hematology at Vanderbilt University, an internal medicine residency at the University of Tennessee, and a medical oncology fellowship at the Fred Hutchinson Cancer Research Center and the University of Washington. He is board certified in internal medicine and medical oncology. He was an associate professor at Shangdong. Dr. Sui believes in treating his patients as if they were his own family members. Dr. Sui is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Lung Cancer, Pleuropulmonary Blastoma, and Large-Cell Immunoblastic Lymphoma.

Dr. Mehta is a multiple time recipient of the Seattle Top Doctor Award and most recently received the 2024 Seattle Magazine Top Doc Award. He enjoys working with patients and family members. There are a wide variety of treatment options available for nearly every patient, so it is important to spend as much time as is needed in order to weight the benefits and risks to any particular approach. He feels that it is important that communication is open and honest. The goals of treatment, whether it is going for cure or maximizing quality of life should be openly discussed and re-discussed as the need arises. Dr. Mehta is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Anal Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, and Cholangiocarcinoma (Bile Duct Cancer).

Dr. Somasundaram Subramaniam is a Medical Oncologist at the Swedish Cancer Institute in Seattle, Washington and a 2021 Seattle Met Top Doctor Award winner. He has specialized expertise in the management of Gastrointestinal (GI) Cancers. This includes common cancers like colon and rectal cancers and also less common cancers like stomach cancer, neuroendocrine tumors (NETs) and liver and bile duct cancers. He also treats patients with lung cancer and kidney cancer. Dr. Soma chose to pursue a career in Oncology to help patients diagnosed with very serious illnesses and their families by providing hope, education and the best opportunities for treatment and cure. He is thrilled to be working with at Swedish, which has an excellent group of caring and highly-trained physicians, nurses and providers who all work very closely together with a robust multi-disciplinary team approach.. Dr. Subramaniam is an investigator on several clinical trials and a key member of the Personalized Medicine Research Program at Swedish, which focuses on the using a tumor’s DNA mutations to target it with newer drugs. The Swedish Cancer Institute prioritizes opening cutting-edge clinical trials to ensure patients have access to the latest innovations in cancer therapy. Dr. Subramaniam graduated from medical school at the National University of Singapore and obtained sub-specialty training during his fellowship at Stanford University, which was supported by a T32 training grant awarded by the National Institutes of Health. He is board-certified in Internal Medicine and Medical Oncology. Dr. Subramaniam also earned a Master of Science degree in Epidemiology and Clinical Research from Stanford. In addition to treating patients with cancer, Dr. Subramaniam is the Medical Director of the Cancer Control program, which emphasizes preventative measures and appropriate cancer screening, to reduce the incidence and burden of cancer in our community. Dr. Subramaniam is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, ALK-Positive Non-Small Cell Lung Cancer, and Nerve Decompression.

"Dr. Fengting Yan is a 2021, 2022, & 2023 Seattle Met Top Doctor Award winner. Dr. Yan is interested in personalized care and translational research in women’s cancer. Extensive lab and clinical research knowledge are applied in her ""bench-to-bedside"" approach to patient care. Dr. Yan also has years of experience in public education on women’s health through internet and TV talk shows.". Dr. Yan is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Breast Cancer in Men, and Inflammatory Breast Cancer.

More people survive cancer now than ever before. I see my role as being a strong advocate for my patients, fully informing them of their options and supporting them throughout their treatment programs. Dr. Fer is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Angiosarcoma.

Dr. Michael Doherty is a Neurologist who specializes in Epilepsy care. He joined the Swedish Neuroscience Institute in 2003 and is the Medical Director of our Epilepsy program. Dr. Doherty works closely with Swedish’s multidisciplinary epilepsy team on state of the art therapies. Specific interests include special needs populations, medication management during pregnancy, new onset seizure, hard-to-treat epilepsy and neurostimulation or surgical treatments of epilepsy. Dr. Doherty was selected by Seattle Magazine as a Top Doctor. Dr. Doherty is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Seizures, Memory Loss, Epilepsy, Knee Replacement, and Hip Replacement.

Dr. Todd Barnett is a multiple time recipient of the Seattle Top Doctor Award and most recently received the 2024 Seattle Magazine Top Doc Award. Dr. Barnett earned his medical degree from Northwestern University, Chicago, Ill. He completed his residency and fellowship at Stanford University, Calif. Dr. Barnett is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Familial Pancreatic Cancer, Pleuropulmonary Blastoma, Lung Cancer, and Follicular Thyroid Cancer.

Dr. Christopher Loiselle is a 2021 Seattle Met Top Doctor Award winner. Dr. Loiselle's philosophy of care is to provide patient-centered, team-directed care while prioritizing the patient's goals and concerns. Patients and their families are often overloaded with information following a diagnosis; Dr. Loiselle's goal is to educate patients and their family members about treatment options and help develop a plan for an optimal outcome. Dr. Loiselle is rated as a Distinguished provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Acoustic Neuroma, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Schwannoma, and Gamma Knife Radiosurgery.

Dr. Charles Cobbs is a Neurosurgeon that specializes in brain tumor surgery, minimally invasive spine surgery, and neurosurgery. He is the Director of The Ben and Catherine Ivy Center for Advanced Brain Tumor Treatment. In his free time he enjoys the outdoors, running, cycling and skiing. Dr. Cobbs was also selected by Seattle Metropolitan Magazine as a Top Doctor in the field of Neurosurgery for consecutive years. Dr. Cobbs is rated as a Distinguished provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, Awake Craniotomy, and Balloon Sinuplasty.

Huong Pham, MD, is a board-certified radiation oncologist with special interest in brain tumors, radiosurgery, breast cancer, prostate cancer and brachytherapy.Dr. Pham strives to be accessible to her patients, welcoming their questions and concerns. In collaboration with her multidisciplinary team, she does everything in her power to give her patients the highest quality, safest and most accurate treatment available.Away from work, Dr. Pham enjoys spending time with her family and playing sports including tennis, snowboarding and surfing. Dr. Pham is rated as a Distinguished provider by MediFind in the treatment of Posterior Fossa Tumor. Her top areas of expertise are Radiation Induced Meningioma, Meningioma, Familial Prostate Cancer, and Posterior Fossa Tumor.

Stephen Thatcher is a Radiation Oncologist in Spokane, Washington. Dr. Thatcher is rated as a Distinguished provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Metastatic Brain Tumor, and Pleuropulmonary Blastoma. Dr. Thatcher is currently accepting new patients.

Wayne Lamoreaux is a Radiation Oncologist in Spokane, Washington. Dr. Lamoreaux is rated as a Distinguished provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Posterior Fossa Tumor, Familial Prostate Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Gamma Knife Radiosurgery. Dr. Lamoreaux is currently accepting new patients.

Christopher Lee is a Radiation Oncologist in Spokane, Washington. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Familial Prostate Cancer, Lung Cancer, Pleuropulmonary Blastoma, Prostate Cancer, and Gamma Knife Radiosurgery. Dr. Lee is currently accepting new patients.

Andrew Bieber is a Neurosurgery provider in Richland, Washington. Dr. Bieber is rated as a Distinguished provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Glioblastoma, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Awake Craniotomy, and Microdiscectomy. Dr. Bieber is currently accepting new patients.

Ying Zhuo is a Hematologist and a Hematologist Oncology provider in Kennewick, Washington. Dr. Zhuo is rated as a Distinguished provider by MediFind in the treatment of Posterior Fossa Tumor. Her top areas of expertise are Chromophobe Renal Cell Carcinoma, Familial Wilms Tumor 2, WT1-Related Wilms Tumor Syndromes, and Paget Disease of the Breast. Dr. Zhuo is currently accepting new patients.